Axela Acquires Xceed Molecular

The deal combines Axela's multiplex protein biomarker testing capabilities and Xceed's Ziplex System for gene expression analysis, with a focus on multiplex diagnostic assays.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.